Admini strative Assistant
Supreme Council of Health
Total years of experience :22 years, 5 Months
1. Walaa Al -Shahed (2014 - Now)
Admini strative Assistant, Supreme Council of Health, Qatar
2. Suzy Sayegh (2013 - Now)
Clinical Trial Coordinator, Supreme Council of Health, Qatar
4. Dr. Paul Arora (2006 -Now)
Chronic Disease Genomics Program Epidemiologist, PHAC, Canada
8. Andre Villegas (2006 - Now)
Chronic Disease Genomics Program Bioinformatician, PHAC, Canada
Supreme Council of Health, Doha, Qatar
February 2013: Applying Handheld Devices in Public Health
Public Health Agency of Canada, Toronto, ON, Canada
March 2010: Aboriginal Health: Northern Science and Technology Strategy
12. Carolina Stryjecki (2012 - 2013)
Chronic Disease Genomics Program Biologist, PHAC, Canada
9. Dr. Soroush Mortaz (2009 - 2013)
Chronic Disease Genomics Program Economist, PHAC, Canada
10. Laura DeCosta (2008 - 2013)
Chronic Disease Genomics Program Molecular Biologist, PHAC, Canada
11. Cristina Cuda (2007 - 2013)
Chronic Disease Genomics Program Molecular Biologist, PHAC, Ca nada
3. Dr. Bibiana Garcia Bailo (2006 - 2013)
Chronic Disease Genomics Program Molecular Biologist, PHAC, Canada
5. Dr. Darren Brenner (2006 -2013)
Chronic Disease Genomics Program Biostatistican, PHAC, Canada
2012: Develop ed the "Office of Research" withi n the Supreme Council of Health, Doha, Qatar.
2007: Established and directed the "Chronic Disease Genomics Program" within the Office of
Biotechnology, Genomics and Population Health, Public Health Agency of Canada, Toronto,
ON, Canada.
diabetes in Canada (published - ClinEcon Outcome Res. 4:91, 2012)
Professional Guidelines & Public Health Practice Division, Public Health Agency of Can ada
Evaluating the co -surveillance of type 2 diabetes and active tuberculosis in the Aboriginal
Canadian Inuit population.
Badawi, A.
13
APPROACH IN TEACHING (BRIEF)
• Foster the acquisition of base of concepts and learning skills to facilitate further learning and scientific thinking.
• Guide the students to the evaluation of evidence, critical thinking, argument development, verbal and written expression, creativity, collaboration and communication skills in addition to the problem -solving skills as well as the applic ation of general principles to novel settings.
• Assist the students to attain a high level of scholarship in specific content areas, especially in graduate courses
• Structuring courses to encompass three common themes: (1) an emphasis on research and resea rch-related tools and skills, (2) the generation and development of science -oriented skills, and (3) the initiation of enthusiasm for scientific inquiry and thinking.
14. Chrissy Wessman (2007 - 2012)
Chronic Disease Genomics Program Policy Analyst, PHAC, Canada
15. Mariola Mascarenhas (2006 - Now)
Chronic Disease Genomics Program Bioinformatician, PHAC, Canada
16. Doaa Farid (2010 - 2011)
Chronic Disease Genomics Program Biologist, PHAC, Canada
13. Dr. Windey Findlay (2006 - 2009)
Chronic Disease Genomics Program Bioinformatician, PHAC, Canada
Badawi, A.
11
7. Laura Williams (2006 - 2009)
Chronic Disease Genomics Program Technician, PHAC, Canada
6. Dr. Mehri Zareie (2008)
Chronic Disease Genomics Program Psychologist, PHAC, Canada
2006: Developed and establish ed the scientific direct ion of the "Canadian Agency for Cancer
Research and Prevention", ON, Canada
Beirut Arab University, Center for Continuing Education, Beirut, Lebanon
May 2006: Nonsteroidal Anti -inflammatory Drugs in Cancer Treatment
May 2006: Cancer: Causes, Detection and Prevention
Spring Semesters 2004/2005
- Molecular Gene tics (BC306)
- Molecular Genetics - Postgraduate (BC501)
- Modern Techniques in Molecular Biology (BC508)
- Quantitative Methods in Biochemistry (BC506)
- Biodiversity and Pollution (B508)
Fall Semesters 2004/2005
- Clinical Biochemistry (BC505)
Invited Lecturer
Thomson Professional Postgraduate Services: Continuing Medical Education, Philadelphia, PA
2003 - 2004
- Molecular Biology in Cancer Prevention and Treatment
Assistant Professor
2000: Established and d irected the: "Laboratory of Biomarkers and Genetic Risk Assessment of
Cancer" at the Division of Population Sciences, Fox Chase Cancer Center, PA, USA
Spring Semesters 1998 - 2000
- Environmental Carcinog enesis (TOX 875)
Environmental Toxicology
Environmental Carcinogenesis
University Staff Lecturer
Department of Environmental Sciences, University of Alexandria, Alexandria, Egypt
Year 199 2
- Environmental Statistics
- Chemical Carcinogenesis
Universit y Staff Instructor/Demonstrator
Department of Environmental Sciences, University of Alexandria, Alexandria, Egypt
1995-99: Research Associate, Department of Nutritional Sc iences, Faculty of Medicine,
University of Toronto, Toronto, ON Canada
1992-95: Visiting Scientist, Division of Molecular Epidemiology, US -Food and Drug and
Administration, Department of Health and Human Services, US -FDA, AR, USA
Jan. 1994: Risk Assessment and Manag ement of Toxic Chemicals.
Dec. 1993: Advances in Cancer Development and Control.
Sept. 1992: Modern Techniques in Applied Biotechnology.
May 1993: Statistical Procedures in Environmental Studies.
STAFF SUPERVISED
Years 1984 -1986
- Environmental Biochemistry
- Statistical Analysis of Environmental Data
- Environmental Instrumentation
Badawi, A.
10
WORKSHOPS ORGANIZ ED, COORDINATED AND LECTURED
Badawi), Dairy Farmers of Canada (DFC) funded $250, 000 for 2 years and Center for Chronic Disease Prevention funded $50, 000 for 2 years ( P.I. Wolever, Co -P.I. Badawi) Total fund: $600, 000 for 3 years (2011 - 2014) 3. Applying nutrigenomics to diabetes prevention in Qatar
Funding: Public Health Agency of Canada funded $700, 000 for 5 years and Center for Chronic Disease Prevention and Control funded $50, 000 for 1 year ( P.I. Badawi) Total fund: $ 750, 000 for 5 years (2008 - 2014) Badawi, A. 5 5. Application of omics to evaluat e the response of the Cree of Eeyou Istchee in Northern Quebec to Aboriginal anti -diabetic medicinal plants in combination with vitamin D.
Duncan (Univ. Guelph), S. Stephenson (Guelph Family Health Team) Synopsis: A clinical study to determ ine the effect of caloric restrictions in combination with vitamin D on the prevention of type 2 diabetes in obese people. We are also exploring the value of lipidomics to elucidate the metabolic adaptation related to the dietary intervention. Funding: Public health Agency of Canada funded $12 0, 000 for 3 years ( P.I. Badawi) Total fund: $120, 000 for 3 years (2011 - 2014) 7. A web -based d atabase of ancestral -related genetic differences in chronic disease risk. Collaborators: M. Karmali, J. Nash, A. Ville gas, C. Wessman, P. Arora (BGPH) Synopsis: A project to develop a web -based database of genetic differences among ethnicities to identify genetic risk factors associated with predisposition to chronic diseases Funding: Public health Agency of Canada funde d $50, 000 for 2 years ( P.I. Badawi)
Total fund: $50, 000 for 2 years (201 1 - 2014) 8. The modifying effect of genetic polymorphisms involved in folate and B12 metabolism on the relationship between folate/B12 intake and vitamin status. Collaborators: H. Morrison, M. deGroh, L. Greene -Finestone (Center for Chronic Disease Prevention and Control, PHAC), A. MacFarlane (Nutrition Science Branch - Food Directorate, Health Canada), R. Duncan (BGPH) Synopsis: A cross -sectional study to elucidate the genetic fa ctors that controls the folate and vitamin B12 serum levels and the response to folate and vitamin B12 supplementation in the Canadian general population. Funding: Genomics Research and Development Initiative (GRDI) funded $300, 000 for 3 years ( P.I. Morri son and Co -P.I. Badawi)
C. Borchers (Genome Br. Columbia, U. Vic. Proteomics Centre), M. Al Thani, (Su preme Council of Health, Qatar), A. Jayyuosi (Hamad Medical Corporation, Qatar), A. Al Hamaq (Qatar Diabetes Association, Qatar), P. Haddad (U of Montreal) Synopsis: to examine the effectiveness and utility of nutrigenomic testing to motivate individuals to adopt healthier nutritional behaviours that reduce the risk of cardiometabolic diseases and developing an omics signature for response to dietary modification Funding: Qatar National Research Fund, QNRF ( P.I. Badawi) Total fund: $900, 000 for 3 years (2014 - 2017) - Under Review
Collaborating Center: College of Biol. Sci., Dept. Human Health and Nutri. Sci. Univ. of Guelph SELECTED MEETINGS, PRESENTATIONS AND INVITED LECTURES 2014: Excellence in Diabetes Meeting (Gu est Speaker), Doha, Qatar 2014: Arab Health Congress - Public Heath Conference, Dubai, UAE.
Total fund: $1, 730, 000 for 6 years (200 7 - 2013) 6. The metabolic adaptation of obese and diabetic patients following high fat/high carbohydrate oral challenge and vitamin D. Collaborators: M. Karmali, P. Arora, D. Brenner, B. Garcia -Bailo (BGPH/PHAC), D. Mutch, A.
Funding: Canadian Institute for Health Research (CIHR) funded $1, 500, 000 for 5 years (2006 - 2011, P.I. Haddad), Public Health Agency of Canada funded $200, 000 for 3 years (2009 - 2012, P.I. Badawi), Center for Chronic Disease Prevention and Control funded $30, 000 for 1 year ( P.I. Badawi)
2010: C entre for Research in Biopharmaceuticals and Biotechnology, University of Ottawa, ON.
2004 - 09: Member, The Quinquennial Review Committee, The Breakthrough Toby Robins Breast Cancer Research Centre, Institute of Cancer Research, London, UK.
2008: Certificate of Education Equivalency, World Education Services, Toronto, Canada 2008: Values and Ethics in the Publ ic Service, Canada School of Public Service - Canada
2008: Orientation to Service s in Public Health, Canada School of Public Service - Canada
2008: Scientific Committee Member, Canadian Institute of Health Research (CIHR) T eam in Aboriginal Anti -diabetic Medicine (TAAM), University of Montreal, Canada. 2008: Member, Natural Health Products Research Society, Canada
2004 - 06: Member, Faculty of Science Council, Beirut Arab University, Beirut, Lebanon
2000 - 06: Reviewer, Chemical Pathology, Metabolic Pathology, Medical Imagining, and Cancer Etiology Study Sections, Center for Scientific Review, National Cancer Institut e (NCI), Nati onal Institutes of Health (NIH), Bethesda, MD, USA.
2002: Prevention of Cancer by Targeting Inflammation ($1, 2 00, 000) National Institutes of Health, National Cancer Institute
1999-2000: Reviewer, Cancer Res. Study Section, U. Nebraska Health System, Omaha, NE, USA.
1993: Certificate of Education Equivalency, World Education Services, New York, USA 1 Please refer to pages 11 - 13 for position responsibilities and duties. Badawi, A. 2 NATIONAL AND INTERNATIONAL ACTIVITIES AND MEMBERSHIPS 2
1993: Award of Scientific Excellence University of Alexandria, Egypt.
1992: Ph.D., Environmental Biology, University of Alexandria, Egypt
1987: M.Sc., Environmental Biology, University of Alexandria, Egypt
1982: B.Sc., Agriculture Sciences, University of Alexandria, Egypt OTHER
Co-Supervision: University of Manchester, U K
2011: Southwest University, Kenner, LA, USA MBA -635 Business Ethics and Responsibilities (3 Semester h ours) MGT -651 Management and Leadership (3 Semester hours) HRM -657 Human Resources Strategic Issues (3 Semester hours)
1994 - Now: Ad-hoc Editor and Reviewer. Examples from over 40 peer-reviewed journals: . The Lancet . International Journal of Clinical Medicine . Nutrition and Metabolism . BMC Public Health . Clinical Investigative Medicin e . CDC Preventing Chronic Diseases . Letters in Drug Design & Discovery . Annals of Public He alth and Research . Journal of Nutritional Health & Food Science . Journal of Clinical and Laboratory Investigation . Journal of Human Nutrition and Food Science . Canadian J. of Physiology and Pharmacology . Current Pharmaceutical Analysis . Advances in B ioscience and Biotechnology . British J. of Medicine and Medical Research . British Journal of Clinical Pharmacolog y . International Journal of Medical Genetics . Journal of Diabetes and Metabolism . Journal of Nutritional Disorders and Therapy . Molecular Genetics and Metabolism . Frontiers in Genetics . PPAR Research . Biochemistry Research International . Yonsei Medical Journal - Korea . Journal of Biotechnology and Biomaterials . Diabetes Metabolism . Diabetes Care . Diabetes . Diabetologia . Journal of Diabetes . Nutrition and Cancer . Clinical Chemistry . Cancer Research . Cancer Detection and Prevention . Cancer Letters . Austin J. of Nutrition and Food S ciences Badawi, A. 4 CURRENTLY FUNDED RESEARCH PROJECTS 1. Nutritional intervention of type II d iabetes mellitus by v itamin D in Qatar (INDDIQAT Clinical Trial)
Collaborators: T. Wolever (U. Toronto), P. Arora (Public Health Agency of Canada), C. Borchers (Genome Br. Columbia, U. Vic. Proteomics Centre), M. Al Thani, (Supreme Council of Health, Qatar), A. Jayy uosi (Hamad Medical Corporation, Qatar), P. Haddad (U. Montreal) Synopsis: A clinical trial in Qatar to examine the efficacy of vitamin D in the prevention of type 2 diabetes and the use of omics technology to assess the response to nutritional interventi on. Funding: Qatar National Research Fund, QNRF (P.I. Badawi) Total fund: $1, 017, 000 for 3 years (201 3 - 2016) 2. Biomarkers of inflammation in the predict ion of type 2 diabetes and response to vitamin D (EVIDENCE Clinical Trial) Collaborators: M. K armali, B. Garcia -Bailo, P. Arora, D. Brenner ( Office of Biotechnology, Genomics and Population Health, Public Health Agency of Canada - BGPH -PHAC), T.
Wolever, A. El -Sohemy (U of Toronto), Reinhold Vieth (Mount Sinai Hospital), P. Haddad (U. Montreal), C. Borchers ( U Victoria -Genome BC Proteomics Centre) . R. Rabasa -Lhoret (CHUM/IRCM), A. Duncan (U of Guelph), H. Morrison ( PHAC) Synopsis: A clinical trial across Canada to assess the effect of vitamin D in the prevention of type 2 diabetes and the use of in flammatory biomarkers for early risk prediction and response to nutritional intervention. Funding: Genomics Research and Development Initiative (GRDI) funded $300, 000 for 3 years (P.I.
Collaborators: A. El -Sohemy (U of Toronto), M. A l-Thani (Dept. Public Health, SCH, Qatar), Novo
Nordisc (Qatar), P. Haddad (U of Montreal), C. Borchers (U of Victoria), Paul Arora ( BGPH - PHAC) Synopsis: This is a randomized controlled intervention clinical trial to test the effectiveness of nutrigenomic testing in a clinical trial setting in the prevention of diabetes complication and will be accompanied by analyzing the proteomic s linked to response to dietary modification. Funding: Novo Nordisc Qatar funded $ 150, 000 for one year with a possible extensi on to 3 years for a total of $750, 000 (P.I. Badawi) Total fund: committed, 150, 000 (2014), remaining $600, 000 for 2 years (20 15 - 2017) 4. Discovery of biomarkers for risk prediction of type 2 diabetes and nutritional intervention.
Collaborators: UK-Twins Registry (King's College, UK) ; A. El -Sohemy, A. Klip, D. Philpott (U of Toronto), B. Rishcards, Z. Dastani (McGill Univ.), P. Haddad (U of Montreal), C. Borchers (U of Victoria), Canadian Health Measures Survey (Health Canada, PHAC, Statistics Canada), B. Garcia -Balio, P. Arora, D. Brenner (BGPH) Synopsis: This is a cross -sectional collaborative international study using large cohort s from Europe and North America to examine the feasibility of employing inflammation as biomarkers of type 2 diabetes ea rly risk prediction.
Collaborators: P. Haddad (University of Montreal), M. Karmali, A. Villegas, C. Wessman, P. Arora, (BGPH, PHAC), D. Cole (University of Toronto), B. Foster ( Therapeutic Products Directorate, TPD, Health Canada) ; P. Sockett (First Nations and Inuit Health Branch, FNIHB, Health
Canada), R. Yada (AFMNet and University of Guelph), J. Arnason (University of Ottawa), J-L. Chiasson (University of Montreal Hospital Research Centre), J. Torrie, P. Linton, D. Dannenbaum, A. Bearskin, F. Awashish (Cree Health Board, Mistissinin), A. Trapper
(Mistissini Community Miyupimaatisiiun Centre, Mistissini CMC -CBHSSJB), M. Awashis h (Cree Elder/ Healer), M. Phillips ( Pharmacogenomics, McGill Univ. Génome Québec Innovation Center) Synopsis: A clinical trial in the Aboriginal community of Misstissini in Northern Quebec to examine the efficacy of traditional anti -diabetic medicine and vitamin D in the prevention of type 2 diabetes and the use of omics technology for biomarker discovery.
2000: Agrochemicals and Human Health: A Framework ($90, 000) Unive rsity of Nebraska Health System PENDING RESEARCH PROP OSALS 1. Applying Nutrigenomics to Cardiometabolic Disease Prevention in Qatar Collaborators: A. El -Sohemy (University of Toronto), P. Arora (Public Health Agency of Canada),
STUDIES COORDINATED AND SUPERVISED (2006 - NOW) 1. Biomarkers for Pre-diabetes: Novel Applications of the Diabetes Population Risk Tool Collaborat ing Center: Ontario Agency for Health Protection and Promotio n 2. Biomarker s of susceptibility to type 2 diabetes along the innate immunity pathway and the modifying effect of dietary fat and vitamin D
Collaborating Center: Depa rtment of Nutritional Sciences, Faculty of Medicine, Univ. of Toronto 5. Applying a novel nanotechnology approach to the early risk prediction of type 2 diabetes
Collaborating Center: Department of Mechanical and Industrial Engineering, Univ. of Toront o 6. Prevention of type 2 diabetes in the Cree of Eeyou Istchee in Northern Quebec: The application of inflammatory biomarkers and vitamin D
Collaborating Center: Department of Pharmacology, Faculty of Medicine, University of Montreal 7. Micronutrie nts and traditional medicine in attenuating health disparities afflicting Canadian Aboriginal populations
Collaborating Center: Department of Pharmacology, Faculty of Medicine, University of Montreal 8. Evidence -based assessment and prioritization of p otential anti -diabetic nutritional factors stemming from Cree traditional medicine.
Collaborating Center: Department of Pharmacology, Faculty of Medicine, University of Montreal Badawi, A. 7 9. Including Aboriginal traditional medicine into health care with a focus on diabetes: A review of the perceptions, barriers, facilitators and models in the Americas to inform knowledge transfer and health policy.
Collaborating Center: Department of Pharmacology, Faculty of Medicine, University of Montreal 10. Association of v itamin D levels with risk for type 2 diabetes in an Aboriginal Canadian community, Sandy Lake, ON
Collaborating Center: Department of Nutritional Sciences, Faculty of Medicine, Univ. of Toronto 11. Influence of inflammatory markers on with obesity and di abetes Collaborating Center: College of Biol. Sci., Dept. Human Health and Nutri. Sci. Univ. of Guelph 12. Association between plasma proteome and vitamins C and E serum levels in humans
Collaborating Center: Department of Nutritional Sciences, Faculty of Medicine, Univ. Toronto 13. Association between vitamin D and cardiometabolic and inflammatory markers in the Canadian Health Measures Survey study. Collaborat ing Center: Department of Nutritional Sciences, Faculty of Medicine, Univ. Toronto 14. Genetics of the interleukin -6 and its effect on insulin resistance
Collaborating Center: Department of Nutritional Sciences, Faculty of Medicine, Univ. Toronto 15. Prevention of obesity in the Canadian Aboriginals: Role of inflammatory biomarkers and vitamin D Collaborating Center: College of Biol. Sci., Dept. Human Health & Nutri. Sci. Univ. of Guelph 16. A custom computer database of human single nucleotide polymorphisms, accompanying search engine, and application for configurable display of search r esults
Collaborat ing Center: Bioinformatics Section, Health Canada, Ottawa. 17. Complications of type 2 diabetes: Role of inflammation
Collaborating Center: Faculty of Medicine, University of Alberta 18. Role of dietary fat and carbohydrate in metab olic abnormalities associated with obesity and type 2 diabetes